Protection of ferrets from infection by swine-origin 2009 a (H1N1) influenza virus by the inactivated vaccine

Viral Immunology

Volumn 23, Issue 4, 2010, Pages 395-402

  Shin, Jin Soo ^a   Hwang, Seon Do ^a   Kim, Hyun Soo ^a   Cho, Sung Whan ^a   Seo, Sang Heui ^a  

^a Chungnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; INACTIVATED INFLUENZA VIRUS A H1N1 VACCINE; INACTIVATED VIRUS VACCINE; INFLUENZA VACCINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; FERRET; INFLUENZA; INFLUENZA VIRUS A H1N1; NONHUMAN; SWINE INFLUENZA;

ANIMALS; ANTIBODIES, VIRAL; ANTIBODY SPECIFICITY; FERRETS; IMMUNIZATION SCHEDULE; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; ORTHOMYXOVIRIDAE INFECTIONS; SWINE; VACCINES, INACTIVATED;

MUSTELA; ORTHOMYXOVIRIDAE; SUIDAE;

EID: 77955899157     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2010.0022     Document Type: Article

References (30)

1. Chowell G, Bertozzi SM, Colchero MA, Lopez-Gatell H, Alpuche-Aranda C, Hernandez M, and Miller MA: Severe respiratory disease concurrent with the circulation of H1N1 influenza. N Engl J Med 2009;361:674-679.
2. Clark TW, Pareek M, Hoschler K, Dillon H, Nicholson KG, Groth N, and Stephenson I: Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361:2424-2435.
3. Couch RB: Seasonal inactivated influenza virus vaccines. Vaccine 2008;26:D5-D9.
4. Garten RJ, Davis CT, Russell CA, et al.: Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009;325:197-1120
5. Gordon CL, Johnson PD, Permezel M, et al.: Association between severe pandemic 2009 influenza A (H1N1) virus infection and immunoglobulin G(2) subclass deficiency. Clin Infect Dis 2010;50:67-678.
6. Govorkova EA, Rehg JE, Krauss S, et al.: Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol 2005;79:2191-2198.
7. Govorkova EA, Webby RJ, Humberd J, Seiler JP, and Webster RG: Immunization with reverse-genetics-produced H5N1 influenza vaccine protects ferrets against homologous and heterologous challenge. J Infect Dis 2006;194:159-167.
8. Greenbaum JA, Kotturi MF, Kim Y, et al.: Pre-existing immunity against swine-origin H1N1 influenza viruses in the general human population. Proc Natl Acad Sci USA 2009; 106:20365-20370.
9. Greenberg ME, Lai MH, Hartel GF, et al.: Response to a monovalent 2009 influenza A (H1N1) vaccine. N Engl J Med 2009;361:2405-2413.
10. Hancock K, Veguilla V, Lu X, et al.: Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009;361:1945-1952.
11. Hoffmann E, Mahmood K, Yang CF, Webster RG, Greenberg HB, and Kemble G: Rescue of influenza B virus from eight plasmids. Proc Natl Acad Sci USA 2002;99:11411-11416.
12. Itoh Y, Shinya K, Kiso M, et al.: In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses. Nature 2009;460:1021-1025.
13. Katz J, Hancock K, Veguilla V, et al.: Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine. MMWR Morb Mortal Wkly Rep 2009;58:521-524.
14. Kawaoka Y, Krauss S, and Webster RG: Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol 1989;63:4603-4608.
15. Kim YH, Kim HS, Cho SH, and Seo SH: Influenza B virus causes milder pathogenesis and weaker inflammatory responses in ferrets than influenza A virus. Viral Immunol 2009;22:423-430.
16. Kobinger GP, Meunier I, Patel A, et al.: Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus. J Infect Dis. 2010; 201:1000-1006.
17. Laver WG, and Webster RG: Studies on the origin of pandemic influenza. Evidence implicating duck and equine influenza viruses as possible progenitors of the Hong Kong strain of human influenza. Virology 1973;51:383-391.
18. Li S, Liu C, Klimov A, et al.: Recombinant influenza A virus vaccines for the pathogenic human A/Hong Kong/97 (H5N1) viruses. J Infect Dis 1999;179:1132-1138.
19. Liang XF, Wang HQ, Wang JZ, et al.: Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebocontrolled trial. Lancet 2010;375:56-66.
20. Maher JA, and DeStefano J: The ferret: an animal model to study influenza virus. Lab Anim (NY) 2004;33:50-53.
21. Maines TR, Jayaraman A, Belser JA, et al.: Transmission and pathogenesis of swine-origin 2009A (H1N1) influenza viruses in ferrets and mice. Science 2009;325:484-487.
22. Munster VJ, de Wit E, van den Brand JM, et al.: Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets. Science 2009;325:481-483.
23. Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team, Dawood FS, Jain S, et al.: Emergence of a novel swineorigin influenza A (H1N1) virus in humans. N Engl J Med 2009;360:2605-2615.
24. Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S, et al.: Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009;361:680-689.
25. Scholtissek C, Rohde W, Von Hoyningen V, and Rott R: On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology 1978;87:13-20.
26. Smith GJ, Vijaykrishna D, Bahl J, et al.: Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 2009;459:1122-1125.
27. Taubenberger JK, Reid AH, Lourens RM, Wang R, Jin G, and Fanning TG: Characterization of the 1918 influenza virus polymerase genes. Nature 2005;437:889-893.
28. Vajo Z, Tamas F, Sinka L, and Jankovics I: Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial. Lancet 2010; 375:49-55.
29. Webby RJ, Perez DR, Coleman JS, et al.: Responsiveness to a pandemic alert: use of reverse genetics for rapid development of influenza vaccines. Lancet 2004;363:1099-1103.
30. Wood JM, Kawaoka Y, Newberry LA, Bordwell E, and Webster RG: Standardization of inactivated H5N2 influenza vaccine and efficacy against lethal A/Chicken/Pennsylvania/ 1370/83infection. Avian Dis 1985;29:867-872.